120 The Professional Counselor | Volume 12, Issue 2 Millar, S. A., Stone, N. L., Bellman, Z. D., Yates, A. S., England, T. J., & O’Sullivan, S. E. (2019). A systematic review of cannabidiol dosing in clinical populations. British Journal of Clinical Pharmacology, 85(9), 1888– 1900. https://doi.org/10.1111/bcp.14038 Mischkowski, D., Crocker, J., & Way, B. M. (2016). From painkiller to empathy killer: Acetaminophen (paracetamol) reduces empathy for pain. Social Cognitive and Affective Neuroscience, 11(9), 1345–1353. https://doi.org/10.1093/scan/nsw057 Mischkowski, D., Crocker, J., & Way, B. M. (2019). A social analgesic? Acetaminophen (paracetamol) reduces positive empathy. Frontiers in Psychology, 10, 538. https://doi.org/10.3389/fpsyg.2019.00538 Mischoulon, D., & Fava, M. (2002). Role of S-adenosyl-L-methionine in the treatment of depression: A review of the evidence. The American Journal of Clinical Nutrition, 76(5), 1158–1161. https://doi.org/10.1093/ajcn/76.5.1158S Modoux, M., Rolhion, N., Mani, S., & Sokol, H. (2020). Tryptophan metabolism as a pharmacological target. Trends in Pharmacological Sciences, 42(1), 60–73. https://doi.org/10.1016/j.tips.2020.11.006 Mulyawan, E., Ahmad, M. R., Islam, A. A., Massi, M. N., Hatta, M., &Arif, S. K. (2020). Analysis of GABRB3 protein level after administration of valerian extract (Valeriana officinalis) in BALB/c mice. Pharmacognosy Journal, 12(4), 821–827. https://doi.org/10.5530/pj.2020.12.118 Murray, C. E., & Murray, T. L., Jr. (2007). The family pharm: An ethical consideration of psychopharmacology in couple and family counseling. The Family Journal, 15(1), 65–71. https://doi.org/10.1177/1066480706294123 Nahin, R. L., Barnes, P. M., Stussman, B. J., & Bloom, B. (2009). Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National Health Statistics Reports, 18, 1–14. https://stacks.cdc.gov/view/cdc/11548 National Institute of Mental Health. (2019). Prevalence of any mental illness (AMI). https://www.nimh.nih.gov/ health/statistics/mental-illness.shtml Newmaster, S. G., Grguric, M., Shanmughanandhan, D., Ramalingam, S., & Ragupathy, S. (2013). DNA barcoding detects contamination and substitution in North American herbal products. BMC Medicine, 11(1), 222. https://doi.org/10.1186/1741-7015-11-222 Ng, C. H., & Bousman, C. A. (2018). Cross-cultural psychopharmacotherapy. In D. Bhugra & K. Bhui (Eds.), Textbook of cultural psychiatry (2nd ed., pp. 432–441). Cambridge University Press. Ng, Q. X., Venkatanarayanan, N., & Ho, C. Y. X. (2017). Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. Journal of Affective Disorders, 210, 211–221. https://doi.org/10.1016/j.jad.2016.12.048 Olsufka, W., &Abraham, M.-A. (2017). Treatment-emergent hypomania possibly associated with over-thecounter supplements. Mental Health Clinician, 7(4), 160–163. https://doi.org/10.9740/mhc.2017.07.160 Pantano, F., Tittarelli, R., Mannocchi, G., Zaami, S., Ricci, S., Giorgetti, R., Terranova, D., Busardò, F. P., & Marinelli, E. (2016). Hepatotoxicity induced by “the 3Ks”: Kava, kratom and khat. International Journal of Molecular Sciences, 17(4), 580. https://doi.org/10.3390/ijms17040580 Papakostas, G. I. (2009). Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. The Journal of Clinical Psychiatry, 70(Suppl. 5), 18–22. https://doi.org/10.4088/JCP.8157su1c.04 Perry, P. J., Alexander, B., Liskow, B. I., & DeVane, C. L. (2006). Psychotropic drug handbook (8th ed.). Lippincott Williams & Wilkins. Phillips, L. A., Cohen, J., Burns, E., Abrams, J., & Renninger, S. (2016). Self-management of chronic illness: The role of ‘habit’ versus reflective factors in exercise and medication adherence. Journal of Behavioral Medicine, 39(6), 1076–1091. https://doi.org/10.1007/s10865-016-9732-z Posadzki, P., Watson, L., & Ernst, E. (2013). Contamination and adulteration of herbal medicinal products (HMPs): An overview of systematic reviews. European Journal of Clinical Pharmacology, 69(3), 295–307. https://doi.org/10.1007/s00228-012-1353-z Preston, J. D., O’Neal, J. H., Talaga, M. C., & Moore, B. A. (2021). Handbook of clinical psychopharmacology for therapists (9th ed.). New Harbinger. PR Newswire. (n.d.). Global over-the-counter drug markets hit $80.2 billion in 2017: Report. https://www.prnewswire. com/news-releases/global-over-the-counter-drug-markets-hit-802-billion-in-2017-report-300588867.html Professional Counselors, 22 Texas Administrative Code § 681.83 (2021). https://texreg.sos.state.tx.us/public/ readtac$ext.ViewTAC?tac_view=5&ti=22&pt=30&ch=681&sch=C&rl=Y
RkJQdWJsaXNoZXIy NDU5MTM1